AnimaBiotech is a pioneering brand utilizing the cutting-edge fusion of mRNA biology and artificial intelligence (AI). Their mRNA Lightning platform revolutionizes the field by discovering small molecule mRNA drugs and uncovering novel mRNA biology targets. With a decade of expertise and a comprehensive understanding of mRNA biology, the platform seamlessly integrates with AI imaging technologies, enabling a visual exploration of the entire life cycle of mRNA in cells.

By harnessing a vast collection of images from healthy and diseased cells, AnimaBiotech trains disease-specific mRNA image analysis neural networks to identify disease signatures and mRNA biology pathways behind various conditions. Furthermore, their tera-scale mRNA biology lab conducts high content screening, identifying active compounds that alter mRNA biology signatures. With the support of their MOAi technologies, AnimaBiotech elucidates the mechanisms of action and molecular targets, propelling their extensive pipeline and collaborations in therapeutic areas such as Immunology, Oncology, and Neuroscience.

With validated science, multiple patents, and numerous scientific collaborations, AnimaBiotech continues to accelerate breakthrough discoveries at an unprecedented speed and success rate